LOGIN
AAOS 2016: Novel EPO dose protocol associated with decreased hospital cost after TKA
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
600 patients scheduled for total knee arthroplasty were randomized to one of three groups: (1) traditional erythropoietin (EPO) dosing, (2) new protocol EPO dosing, or (3) placebo injection. The purpose of this study was to investigate and compare the two EPO dosing protocols with the placebo group by assessing hemoglobin levels, the requirement of postoperative transfusion, cost of hospital stay,...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.